Efficacy and safety of a 14-day administration of tolvaptan in the treatment of patients with ascites in hepatic oedema

The Pharmacokinetics and Pharmacodynamics of Tolvaptan in Patients with Liver Cirrhosis with Insufficient Response to Conventional Diuretics: a Multicentre, Double-blind, Parallel-group, Phase III Study

(2013) I Sakaida et al.   JOURNAL OF INTERNATIONAL MEDICAL RESEARCH

Diagnostic criteria of acute liver failure: A report by the Intractable Hepato-Biliary Diseases Study Group of Japan

(2011) Satoshi Mochida et al.   HEPATOLOGY RESEARCH

Management of ascites in cirrhosis

(2011) Florence Wong   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Diuretic Strategies in Patients with Acute Decompensated Heart Failure

(2011) G. Michael Felker et al.   NEW ENGLAND JOURNAL OF MEDICINE

Management of hyponatremia: Providing treatment and avoiding harm

(2010) C. VAIDYA et al.   CLEVELAND CLINIC JOURNAL OF MEDICINE

A multicenter, open-label, dose-ranging study to exploratively evaluate the efficacy, safety, and dose–response of tolvaptan in patients with decompensated liver cirrhosis

(2010) Kiwamu Okita et al.   JOURNAL OF GASTROENTEROLOGY

EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis

(2010)   JOURNAL OF HEPATOLOGY

The 2008 Declaration of Helsinki: some reflections

(2010) S. Giordano   JOURNAL OF MEDICAL ETHICS

Management of adult patients with ascites due to cirrhosis: An update

(2009) Bruce A. Runyon   HEPATOLOGY

Treatment of Hyponatremia

(2008) Peter Gross   INTERNAL MEDICINE

Non-peptide arginine-vasopressin antagonists: the vaptans

(2008) Guy Decaux et al.   LANCET

Assessment of Prognosis of Cirrhosis

(2008) François Durand et al.   SEMINARS IN LIVER DISEASE